These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35505833)

  • 1. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study.
    Ouldali N; Bagheri H; Salvo F; Antona D; Pariente A; Leblanc C; Tebacher M; Micallef J; Levy C; Cohen R; Javouhey E; Bader-Meunier B; Ovaert C; Renolleau S; Hentgen V; Kone-Paut I; Deschamps N; De Pontual L; Iriart X; Guen CG; Angoulvant F; Belot A;
    Lancet Reg Health Eur; 2022 Jun; 17():100393. PubMed ID: 35505833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study.
    Schwartz N; Ratzon R; Hazan I; Zimmerman DR; Singer SR; Wasser J; Dweck T; Alroy-Preis S
    Eur J Pediatr; 2024 Aug; 183(8):3319-3326. PubMed ID: 38724677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
    Cortese MM; Taylor AW; Akinbami LJ; Thames-Allen A; Yousaf AR; Campbell AP; Maloney SA; Harrington TA; Anyalechi EG; Munshi D; Kamidani S; Curtis CR; McCormick DW; Staat MA; Edwards KM; Creech CB; Museru O; Marquez P; Thompson D; Su JR; Schlaudecker EP; Broder KR
    J Infect Dis; 2023 Jul; 228(2):143-148. PubMed ID: 36821777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Orzel AO; Young CC; Boom JA; Sahni LC; Maddux AB; Bline KE; Kamidani S; Tarquinio KM; Chiotos K; Schuster JE; Cullimore ML; Heidemann SM; Hobbs CV; Nofziger RA; Pannaraj PS; Cameron MA; Walker TC; Schwartz SP; Michelson KN; Coates BM; Flori HR; Mack EH; Smallcomb L; Gertz SJ; Bhumbra SS; Bradford TT; Levy ER; Kong M; Irby K; Cvijanovich NZ; Zinter MS; Bowens C; Crandall H; Hume JR; Patel MM; Campbell AP; Randolph AG;
    Clin Infect Dis; 2023 Feb; 76(3):e90-e100. PubMed ID: 35924406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Boom JA; Sahni LC; Kamidani S; Tarquinio KM; Maddux AB; Heidemann SM; Bhumbra SS; Bline KE; Nofziger RA; Hobbs CV; Bradford TT; Cvijanovich NZ; Irby K; Mack EH; Cullimore ML; Pannaraj PS; Kong M; Walker TC; Gertz SJ; Michelson KN; Cameron MA; Chiotos K; Maamari M; Schuster JE; Orzel AO; Patel MM; Campbell AP; Randolph AG;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):52-58. PubMed ID: 35025852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
    Buchhorn R; Meyer C; Schulze-Forster K; Junker J; Heidecke H
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisystem Inflammatory Syndrome in Children (MIS-C), Possibly Due to COVID-19 mRNA Vaccination.
    Keka-Sylaj A; Ramosaj A; Baloku A; Zogaj L; Gjaka P
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria.
    Liguori V; Zinzi A; Gaio M; Riccardi C; Di Costanzo L; Gargano F; Carpentieri C; D'Elia M; Bernardi FF; Trama U; Capuano A; Rafaniello C
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
    Kildegaard H; Lund LC; Højlund M; Stensballe LG; Pottegård A
    BMJ; 2022 Apr; 377():e068898. PubMed ID: 35410884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
    Ludwikowska KM; Popiel A; Matkowska-Kocjan A; Biela M; Wójcik M; Szenborn F; Wielgos K; Pielka-Markiewicz E; Zaryczański J; Kursa MB; Szenborn L
    Vaccine; 2023 May; 41(21):3317-3327. PubMed ID: 37087396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination.
    Villena R; Izquierdo G; Wilhelm J; García C; Acuña M; Riquelme P; Alvarado S; Torres JP
    Vaccine; 2024 Sep; 42(22):126015. PubMed ID: 38852034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effects of pediatric vaccination on multisystem inflammatory syndrome in children stratified by vaccine status, types and virus variants.
    Zhang YF; Xia CY; Yang Q; Cai Y; Li DT; Jiang Q; Hu P
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111105. PubMed ID: 38149578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review.
    Mastrolia MV; De Cillia C; Orlandi M; Abu-Rumeileh S; Maccora I; Maniscalco V; Marrani E; Pagnini I; Simonini G
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
    Payne AB; Gilani Z; Godfred-Cato S; Belay ED; Feldstein LR; Patel MM; Randolph AG; Newhams M; Thomas D; Magleby R; Hsu K; Burns M; Dufort E; Maxted A; Pietrowski M; Longenberger A; Bidol S; Henderson J; Sosa L; Edmundson A; Tobin-D'Angelo M; Edison L; Heidemann S; Singh AR; Giuliano JS; Kleinman LC; Tarquinio KM; Walsh RF; Fitzgerald JC; Clouser KN; Gertz SJ; Carroll RW; Carroll CL; Hoots BE; Reed C; Dahlgren FS; Oster ME; Pierce TJ; Curns AT; Langley GE; Campbell AP; ; Balachandran N; Murray TS; Burkholder C; Brancard T; Lifshitz J; Leach D; Charpie I; Tice C; Coffin SE; Perella D; Jones K; Marohn KL; Yager PH; Fernandes ND; Flori HR; Koncicki ML; Walker KS; Di Pentima MC; Li S; Horwitz SM; Gaur S; Coffey DC; Harwayne-Gidansky I; Hymes SR; Thomas NJ; Ackerman KG; Cholette JM
    JAMA Netw Open; 2021 Jun; 4(6):e2116420. PubMed ID: 34110391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program.
    Rao S; Jing N; Liu X; Lorman V; Maltenfort M; Schuchard J; Wu Q; Tong J; Razzaghi H; Mejias A; Lee GM; Pajor NM; Schulert GS; Thacker D; Jhaveri R; Christakis DA; Bailey LC; Forrest CB; Chen Y
    medRxiv; 2022 Sep; ():. PubMed ID: 36203555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.